Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1H-pyrazolo[3,4-d]pyrimidine-4-amino Side Chain

• Published in: Molecules (Basel, Switzerland) Switzerland), 2023-05, Vol.28 (9), p.3975
• Main Authors: Wang, Jun, Hu, Yu-Han, Zhou, Ke-Xin, Wang, Wei, Li, Fei, Li, Ke, Zhang, Guang-Yu, Tang, You-Zhi
• Format: Article
• Language: English
• Subjects: 1H-pyrazolo[3,4-d]pyrimidine; Antibacterial activity; Antibiotics; Antimicrobial agents; Bacterial infections; Bactericidal activity; Binding; Cell viability; Dilution; Drug resistance; Hydrogen bonding; Hydrogen bonds; In vivo methods and tests; Methicillin; Minimum inhibitory concentration; Molecular docking; MRSA; Neutropenia; Pathogens; pleuromutilin; Pneumonia; Pyrazole; Pyrazoles; Staphylococcus aureus; Staphylococcus infections; Thigh; Tiamulin
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28093975

Two series of pleuromutilin derivatives were designed and synthesized as inhibitors against Staphylococcus aureus (S. aureus). 6-chloro-4-amino-1-R-1H-pyrazolo[3,4-d]pyrimidine or 4-(6-chloro-1-R-1H-pyrazolo[3,4-d]pyrimidine-4-yl)amino-phenylthiol were connected to pleuromutilin. A diverse array of substituents was introduced at the N-1 position of the pyrazole ring. The in vitro antibacterial activities of these semisynthetic derivatives were evaluated against two standard strains, Methicillin-resistant Staphylococcus aureus (MRSA) ATCC 43300, Staphylococcus aureus (S. aureus), ATCC 29213 and two clinical S. aureus strains (144, AD3) using the broth dilution method. Compounds 12c, 19c and 22c (MIC = 0.25 μg/mL) manifested good in vitro antibacterial ability against MRSA which was similar to that of tiamulin (MIC = 0.5 μg/mL). Among them, compound 22c killed MRSA in a time-dependent manner and performed faster bactericidal kinetics than tiamulin in time–kill curves. In addition, compound 22c exhibited longer PAE than tiamulin, and showed no significant inhibition on the cell viability of RAW 264.7, Caco-2 and 16-HBE cells at high doses (≤8 μg/mL). The neutropenic murine thigh infection model study revealed that compound 22c displayed more effective in vivo bactericidal activity than tiamulin in reducing MRSA load. The molecular docking studies indicated that compound 22c was successfully localized inside the binding pocket of 50S ribosomal, and four hydrogen bonds played important roles in the binding of them.